Clinical trial for Liver Disease Chronic
Official title Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
ClinicalTrials.gov ID: NCT07487623
What this study is testing
- What it's testing
- This study is testing whether the supplement improves liver health markers and outcomes compared to whey protein alone.
- Who it's for
- You may be able to join if you have liver disease caused by chronic hepatitis C infection.
- What's involved
- You will take the supplement or whey protein every day for 12 weeks. You will visit the clinic every 4 weeks for blood tests and health checks.
- Time commitment
- The study lasts 12 weeks and requires four clinic visits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 69
You may be able to join if
- Patients with liver disease secondary to chronic hepatitis C virus infection who attend the outpatient Hepatitis Clinic of the Gastroenterology...
- Child-Pugh score \< 8 points. Age 18-69 years. Both sexes. Signed informed consent.
You likely can't join if
- Patients with alcohol consumption within the past 6 months. Patients with a history of acute-on-chronic liver failure (ACLF).
The study team makes the final eligibility decision.
Where it is enrolling
- Guadalajara, Jalisco, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Guadalajara, Jalisco, Mexico. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.